Skip to main content

2014 | OriginalPaper | Buchkapitel

8. Peritonealdialyse (PD)

verfasst von : Dr. med. Steffen Geberth, Dr. med. Rainer Nowack

Erschienen in: Praxis der Dialyse

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Die PD stellt heute einerseits ein Konkurrenzverfahren zur Hämodialyse (HD) dar, andererseits wird sie auch als „Einstiegsverfahren“ bei noch relativ guter Nierenrestfunktion propagiert. Ihr Anteil an den Nierenersatzverfahren weist weltweit große regionale Unterschiede auf. Ihr Anteil ging in den USA von 18% in 1994 auf ca. 8% in 2005 zurück (United States Renal Data System, USRDS 2005). In Deutschland ist der Anteil der PD-Patienten seit Jahren unterdurchschnittlich gering, mit ebenfalls rückläufiger Tendenz (1996 ca. 7,3%, 2005 ca. 4,9%; Quelle: Quasi-Niere Bericht 2005).
Literatur
Zurück zum Zitat Anonymous (1997) NKF-DOQI Clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30 (Suppl 2): S67–S136CrossRef Anonymous (1997) NKF-DOQI Clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30 (Suppl 2): S67–S136CrossRef
Zurück zum Zitat Baragetti I, Alberghini E, Scanziani R et al (2009 )The APD treatment with a cycler personalised breakpoint improves peritoneal dialytic Kt/V: Baragetti I, Alberghini E, Scanziani R et al (2009 )The APD treatment with a cycler personalised breakpoint improves peritoneal dialytic Kt/V:
Zurück zum Zitat a pilot study. Poster Presentation at World Congress of Nephrology, Milan 2009 a pilot study. Poster Presentation at World Congress of Nephrology, Milan 2009
Zurück zum Zitat Bergström J, Heimbürger O, Lindholm B (1998) Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 18: 467–473PubMed Bergström J, Heimbürger O, Lindholm B (1998) Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 18: 467–473PubMed
Zurück zum Zitat Blake P, Burkart JM, Churchill DN et al. (1996) Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int. Sep–Oct;16(5):448–456 Blake P, Burkart JM, Churchill DN et al. (1996) Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int. Sep–Oct;16(5):448–456
Zurück zum Zitat Churchill DN et al., for CANUSA-study investigators (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study group. J Am Soc Nephrol. Feb;7(2):198–207 Churchill DN et al., for CANUSA-study investigators (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study group. J Am Soc Nephrol. Feb;7(2):198–207
Zurück zum Zitat Cocchi R, Degli Esposti E, Fabbri A et al. (1999) Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant. Jun;14(6):1536–1540PubMedCrossRef Cocchi R, Degli Esposti E, Fabbri A et al. (1999) Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant. Jun;14(6):1536–1540PubMedCrossRef
Zurück zum Zitat Demoulin N, Goffin E (2009) Intrapertioneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis.Perit. Dial. Int. 29(5): 548–553PubMed Demoulin N, Goffin E (2009) Intrapertioneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis.Perit. Dial. Int. 29(5): 548–553PubMed
Zurück zum Zitat De Vecchi AF, Colucci P, Salerno F, Scalamogna A, Ponticelli C (2002) Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure Am J Kidney Dis. Jul;40(1):161–168 De Vecchi AF, Colucci P, Salerno F, Scalamogna A, Ponticelli C (2002) Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure Am J Kidney Dis. Jul;40(1):161–168
Zurück zum Zitat Diaz-Buxo JA, Farmer CD, Walker PJ et al. (1981) Continuous cyclic peritoneal dialysis- a preliminary report. Artif Organs 5: 157–161PubMedCrossRef Diaz-Buxo JA, Farmer CD, Walker PJ et al. (1981) Continuous cyclic peritoneal dialysis- a preliminary report. Artif Organs 5: 157–161PubMedCrossRef
Zurück zum Zitat Di Paolo N, Capotondo L, Sansoni E, Romolini V, Simola M, Gaggiotti E, et al. The self-locating catheter: clinical experience and follow-up. Perit Dial Int 2004;24 :359–69PubMed Di Paolo N, Capotondo L, Sansoni E, Romolini V, Simola M, Gaggiotti E, et al. The self-locating catheter: clinical experience and follow-up. Perit Dial Int 2004;24 :359–69PubMed
Zurück zum Zitat Dombros N, Dratwa M, Feriani M et al.; EBPG Expert Group on Peritoneal Dialysis (2005) European Best Practice Guidelines on Peritoneal Dialysis 2005. Nephrol Dial Transplant. Dec;20 Suppl 9 Dombros N, Dratwa M, Feriani M et al.; EBPG Expert Group on Peritoneal Dialysis (2005) European Best Practice Guidelines on Peritoneal Dialysis 2005. Nephrol Dial Transplant. Dec;20 Suppl 9
Zurück zum Zitat Durand PY, Tam P et al. (2005) Optimization and personalization of APD based on the individual drain flow profile (BREAKpoint-APD), Ontario Durand PY, Tam P et al. (2005) Optimization and personalization of APD based on the individual drain flow profile (BREAKpoint-APD), Ontario
Zurück zum Zitat Scarborough Hospital. Oral presentation at Euro PD, 2005 Scarborough Hospital. Oral presentation at Euro PD, 2005
Zurück zum Zitat Enia G, Sicuso C, Alati G, Zoccali C (1993) Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8: 1094–1098PubMed Enia G, Sicuso C, Alati G, Zoccali C (1993) Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8: 1094–1098PubMed
Zurück zum Zitat Figueireko A, Goh B-L, Jenkins S, et al. (2010) Clinical practice guidelines for peritoneal access. Perit Dial Int 30: 424–429.CrossRef Figueireko A, Goh B-L, Jenkins S, et al. (2010) Clinical practice guidelines for peritoneal access. Perit Dial Int 30: 424–429.CrossRef
Zurück zum Zitat Gokal et al. (2002) Metabolic and laboratory effects of icodextrin. Kidney Int 62 (Suppl 81):S62–S71CrossRef Gokal et al. (2002) Metabolic and laboratory effects of icodextrin. Kidney Int 62 (Suppl 81):S62–S71CrossRef
Zurück zum Zitat Haag-Weber M, Krämer R, Haake R et al. (2010) Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant 25(7):2288–96.PubMedCrossRef Haag-Weber M, Krämer R, Haake R et al. (2010) Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant 25(7):2288–96.PubMedCrossRef
Zurück zum Zitat Khalifeh N, Vychytil A, Hörl WH (2006) Peritonealdialyse bei therapieresistenter Herzinsuffizienz. Nephro-News, Dezember 7–8 Khalifeh N, Vychytil A, Hörl WH (2006) Peritonealdialyse bei therapieresistenter Herzinsuffizienz. Nephro-News, Dezember 7–8
Zurück zum Zitat Keshaviah P, Nolph KD, Moore HL et al. (1994) Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4: 1475–1485PubMed Keshaviah P, Nolph KD, Moore HL et al. (1994) Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4: 1475–1485PubMed
Zurück zum Zitat Konings CJ, Kooman JP, Schonck M et al. (2003) Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant. Apr;18(4):797–803PubMedCrossRef Konings CJ, Kooman JP, Schonck M et al. (2003) Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant. Apr;18(4):797–803PubMedCrossRef
Zurück zum Zitat La Milia et al. (2002) The mini peritoneal equilibration test (mini-PET). Nephrol Dial Transplant 17(Suppl 3):17–18 La Milia et al. (2002) The mini peritoneal equilibration test (mini-PET). Nephrol Dial Transplant 17(Suppl 3):17–18
Zurück zum Zitat Lang SM, Bergner A, Töpfer M, Schiffl H (2001) Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int. Jan–Feb;21(1):52–57PubMed Lang SM, Bergner A, Töpfer M, Schiffl H (2001) Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int. Jan–Feb;21(1):52–57PubMed
Zurück zum Zitat Li P K-T, Szeto CC, Piraino B, Bernardini J et al. (2010) ISPD Guideline/Recommendations: Peritoneal dialysis-related Infections recommendations: 2010 Update. Perit Dial Int 30: 393 -432.PubMedCrossRef Li P K-T, Szeto CC, Piraino B, Bernardini J et al. (2010) ISPD Guideline/Recommendations: Peritoneal dialysis-related Infections recommendations: 2010 Update. Perit Dial Int 30: 393 -432.PubMedCrossRef
Zurück zum Zitat Moist LM, Port FK et al. (2000) Predictors of loss of residual renal function among new dialysis patients.J Am Soc Nephrol. Mar;11(3):556–564PubMed Moist LM, Port FK et al. (2000) Predictors of loss of residual renal function among new dialysis patients.J Am Soc Nephrol. Mar;11(3):556–564PubMed
Zurück zum Zitat Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. Nov;16(11):2207–2213PubMedCrossRef Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. Nov;16(11):2207–2213PubMedCrossRef
Zurück zum Zitat Misra M, Vonesh E, Van Stone JC, Moore HL, Prowant B, Nolph KD (2001) Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int. Feb;59(2):754–763PubMedCrossRef Misra M, Vonesh E, Van Stone JC, Moore HL, Prowant B, Nolph KD (2001) Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int. Feb;59(2):754–763PubMedCrossRef
Zurück zum Zitat Moritz ML, del Rio M, Crooke GA, Singer LP (2001) Acute peritoneal dialysis as bothe cause and treatment of hypernatremia in an infant. Pediatr Nephrol. Sep;16(9):697–700PubMedCrossRef Moritz ML, del Rio M, Crooke GA, Singer LP (2001) Acute peritoneal dialysis as bothe cause and treatment of hypernatremia in an infant. Pediatr Nephrol. Sep;16(9):697–700PubMedCrossRef
Zurück zum Zitat Nowack R, Birck R, Weinreich T (2009) Dialyse und Nephrologie für Fachpersonal. 3. Auflage, Springer HeidelbergCrossRef Nowack R, Birck R, Weinreich T (2009) Dialyse und Nephrologie für Fachpersonal. 3. Auflage, Springer HeidelbergCrossRef
Zurück zum Zitat Oreopoulos DG, Robson M, Izatt S et al. (1978) A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24: 484–489PubMed Oreopoulos DG, Robson M, Izatt S et al. (1978) A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24: 484–489PubMed
Zurück zum Zitat Pandya BK, Friede T, Williams JD (2004) A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis. Perit Dial Int. Jan-Feb;24(1):79–81PubMed Pandya BK, Friede T, Williams JD (2004) A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis. Perit Dial Int. Jan-Feb;24(1):79–81PubMed
Zurück zum Zitat Paniagua R, Amato D, Vonesh E et al.; Mexican Nephrology Collaborative Study Group (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. May;13(5):1307–1320PubMed Paniagua R, Amato D, Vonesh E et al.; Mexican Nephrology Collaborative Study Group (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. May;13(5):1307–1320PubMed
Zurück zum Zitat Piraino B et al.; for ISPD ad hoc advisory committee (2005) Peritoneal dialysis-related infections recommendations: 2005 update.Perit Dial Int. Mar–Apr;25(2):107–131PubMed Piraino B et al.; for ISPD ad hoc advisory committee (2005) Peritoneal dialysis-related infections recommendations: 2005 update.Perit Dial Int. Mar–Apr;25(2):107–131PubMed
Zurück zum Zitat Popovich RP, Moncrief JW, Decherd JF et al. (1976) The definition of a novel portable-wearable equilibrium peritoneal technique (Abstract). Am Soc Artif Intern Organs 22: 64 Popovich RP, Moncrief JW, Decherd JF et al. (1976) The definition of a novel portable-wearable equilibrium peritoneal technique (Abstract). Am Soc Artif Intern Organs 22: 64
Zurück zum Zitat Rippe B (1993) The three-pore model of peritoneal transport. Perit Dial Int 13:535 Rippe B (1993) The three-pore model of peritoneal transport. Perit Dial Int 13:535
Zurück zum Zitat Rippe B, Zakaria ER (1992) Lymphatic versus nonlymphatic fluid adsorption from the peritoneal cavity as related to the peritoneal ultrafiltration capacity and sieving properties. Blood Purif 10: 189–202PubMedCrossRef Rippe B, Zakaria ER (1992) Lymphatic versus nonlymphatic fluid adsorption from the peritoneal cavity as related to the peritoneal ultrafiltration capacity and sieving properties. Blood Purif 10: 189–202PubMedCrossRef
Zurück zum Zitat Rippe B, Venturoli D, Simonsen O, de Arteaga J (2004) Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int. Jan–Feb;24(1):10–27PubMed Rippe B, Venturoli D, Simonsen O, de Arteaga J (2004) Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int. Jan–Feb;24(1):10–27PubMed
Zurück zum Zitat Schaefer F, Klaus G, Mueller-Wiefel DE, Mehls O (1999) Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol 10(1): 136–145PubMed Schaefer F, Klaus G, Mueller-Wiefel DE, Mehls O (1999) Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol 10(1): 136–145PubMed
Zurück zum Zitat Schwenger V (2007) PD-assoziierte Peritonitis. Nephrologe 2: 107–118CrossRef Schwenger V (2007) PD-assoziierte Peritonitis. Nephrologe 2: 107–118CrossRef
Zurück zum Zitat Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B (2003) Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States Kidney Int. Sep;64(3):1071–1079 Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B (2003) Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States Kidney Int. Sep;64(3):1071–1079
Zurück zum Zitat Tenckhoff H, Schechter H (1968) A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 14: 181–187PubMed Tenckhoff H, Schechter H (1968) A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 14: 181–187PubMed
Zurück zum Zitat Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group (2004) Relative contribution of residual renal function and different measures of adequacy to survival in hemodialyis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.J Am Soc Nephrol. Apr;15(4):1061–1070 Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group (2004) Relative contribution of residual renal function and different measures of adequacy to survival in hemodialyis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.J Am Soc Nephrol. Apr;15(4):1061–1070
Zurück zum Zitat Twardowski ZJ (1990) PET – a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial. 6:186–191PubMed Twardowski ZJ (1990) PET – a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial. 6:186–191PubMed
Zurück zum Zitat Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH (2000) An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol Jan;11(1):116–125 Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH (2000) An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol Jan;11(1):116–125
Zurück zum Zitat Vychytil A (2007) Peritonealdialyse bei Patienten mit Diabetes. Diabetes, Stoffwechsel und Herz 1: 23–31 Vychytil A (2007) Peritonealdialyse bei Patienten mit Diabetes. Diabetes, Stoffwechsel und Herz 1: 23–31
Zurück zum Zitat Wens et al. (1998) A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int 18:603–609PubMed Wens et al. (1998) A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int 18:603–609PubMed
Zurück zum Zitat Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J; Euro Balance Trial Group (2004) The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. Jul;66(1):408–418 Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J; Euro Balance Trial Group (2004) The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. Jul;66(1):408–418
Metadaten
Titel
Peritonealdialyse (PD)
verfasst von
Dr. med. Steffen Geberth
Dr. med. Rainer Nowack
Copyright-Jahr
2014
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-642-41208-0_8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.